financetom
Business
financetom
/
Business
/
What's Going On With Nikola Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Nikola Stock?
Jun 27, 2024 1:20 PM

Nikola Corporation ( NKLA ) shares are trading lower Thursday. Nikola ( NKLA ) effected a 1-for-30 reverse stock split after the closing bell Monday and shares commenced trading on a split-adjusted basis Tuesday morning.

What To Know:

Nikola's ( NKLA ) stock saw a brief rally Wednesday as the broader EV market saw a boost on news of a joint-venture between Rivian Automotive and Volkswagen.  

However, Nikola ( NKLA ) shares have given back Wednesday gains and continue to fall post-reverse split. The stock is down nearly 50% over the past month. 

The company faces a rocky road ahead and is set to be removed from the Russell 3000 Index. The company's first-quarter  financial results saw a decline in total revenues and a net loss per share of $2.70. 

Nikola ( NKLA ) will report its second-quarter results later in the summer with analysts anticipating losses of 9 cents per share and revenue of $21.35 million, according to estimates from Benzinga Pro.

Related News: Levi Strauss Stock Plummets On Mixed Q2 Results, Weak Guidance: The Details

Will NKLA Stock Go Up?

When trying to assess whether or not Nikola ( NKLA ) will trade higher from current levels, it's a good idea to take a look at analyst forecasts.

In the last month, one analyst has adjusted price targets. Here's a look at recent price target changes [Analyst Ratings]. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Nikola ( NKLA ) have performed in recent history.

Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Nikola ( NKLA ) is 77.92% down year-to-date. The average analyst price target suggests the stock could have further downside ahead.

For a broad overview of everything you need to know about Nikola ( NKLA ), visit here. If you want to go above and beyond, there's no better tool to help you do just that than Benzinga Pro. Start your free trial today.

NKLA Price Action: According to Benzinga Pro, Nikola ( NKLA ) shares are down 12.8% at $8.64 at the time of publication Thursday.

Image: Courtesy of Nikola Corporation ( NKLA )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Healthcare firm McKesson's Q2 revenue slightly misses estimates
Healthcare firm McKesson's Q2 revenue slightly misses estimates
Nov 5, 2025
Overview * McKesson Corp ( MCK ) fiscal Q2 rev grows 10% yr/yr, slightly missing analyst expectations * Adjusted EPS for fiscal Q2 beats consensus, rising 39% yr/yr * Company raises fiscal 2026 adjusted EPS guidance, indicating confidence in growth strategy Outlook * McKesson raises fiscal 2026 adjusted EPS guidance to $38.35-$38.85, from the previous range of $38.05 to $38.55...
STERIS Fiscal Q2 Adjusted Earnings, Revenue Rise; 2026 EPS Guidance Revised
STERIS Fiscal Q2 Adjusted Earnings, Revenue Rise; 2026 EPS Guidance Revised
Nov 5, 2025
05:07 PM EST, 11/05/2025 (MT Newswires) -- STERIS ( STE ) reported fiscal Q2 adjusted earnings late Wednesday of $2.47 per diluted share, up from $2.14 a year earlier. Analysts polled by FactSet expected $2.35. Revenue for the three months ended Sept. 30 was $1.46 billion, up from $1.33 billion a year earlier. Analysts surveyed by FactSet expected $1.43 billion....
Pfizer Responds to Delaware Chancery Court Ruling
Pfizer Responds to Delaware Chancery Court Ruling
Nov 5, 2025
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. ( PFE ) today issued the following statement in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to prevent Metsera, Inc. from terminating the existing merger agreement in favor of a competing proposal from Novo Nordisk. “We remain confident in the merits of our claims and our belief...
GeoPark Q3 revenue beats expectations driven by higher production
GeoPark Q3 revenue beats expectations driven by higher production
Nov 5, 2025
Overview * GeoPark ( GPRK ) Q3 revenue beats analyst expectations, driven by higher production and stable prices * Company reports Q3 net profit of $15.9 mln, reversing a loss from 2Q2025 * GeoPark ( GPRK ) completes Vaca Muerta acquisition, enhancing growth prospects Outlook * GeoPark ( GPRK ) targets 2030 production of 42,000-46,000 boepd * Company plans to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved